Previously, IRDye800 was used to label a 14-mer peptide targeting the gastrin-releasing peptide receptor (GRPR), which was safely utilized in image-guided surgeries of glioblastoma multiforme in n = 29 patients [43]. The gene discussed is GRPR; the disease is glioblastoma.